Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2020 13:04 ET | Source: Rigrodsky & Long, P.A.

PFENEX INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

WILMINGTON, Del., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Pfenex Inc. (“Pfenex”) (NYSE American: PFNX) regarding possible breaches of...
May 06, 2019 09:00 ET | Source: Novan, Inc.

Novan Completes Funding Transaction with Ligand Pharmaceuticals

Novan to immediately receive $12 million of non-dilutive capitalLigand to receive milestones and tiered royalty for North America SB206 molluscum indicationPhase 3 molluscum trial to begin recruitment...
January 11, 2017 13:20 ET | Source: Shareholders Foundation, Inc.

Deadline in Lawsuit for Investors in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) announced by Shareholders Foundation

SAN DIEGO, Jan. 11, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on January 17, 2017 in the lawsuit that was filed for certain investors in...
January 05, 2017 13:52 ET | Source: The Rosen Law Firm PA

LGND LOSS ALERT: Rosen Law Firm Reminds Ligand Pharmaceuticals Incorporated Investors of Important January 17 Deadline in Class Action Filed by Firm - LGND

NEW YORK, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Ligand Pharmaceuticals Incorporated securities (NASDAQ:LGND) from November 9,...
December 21, 2016 13:01 ET | Source: The Rosen Law Firm PA

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ligand Pharmaceuticals Incorporated - LGND

NEW YORK, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Ligand Pharmaceuticals...
November 29, 2016 13:35 ET | Source: Shareholders Foundation, Inc.

Lawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of Securities Laws announced by Shareholders Foundation

SAN DIEGO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in California on behalf of certain purchasers of shares of Ligand Pharmaceuticals...